This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Levine, R. L. Articles by Bee, N. Search for Related Content PubMed PubMed Citation Articles by Levine, R. L. Articles by Bee, N.

Stroke, Vol 23, 839-842, Copyright © 1992 by American Heart Association

ARTICLES

Stroke and Parkinson's disease

RL Levine, JC Jones and N Bee
Department of Neurology, Middleton Veterans Affairs Hospital, Madison, Wis.

BACKGROUND AND PURPOSE: We sought to determine whether the recently reported decreased incidence of stroke and atherosclerotic disease in a university hospital-based Parkinson's disease patient population would be demonstrated in our patient population. METHODS: We performed a retrospective case-control review of the last 119 Parkinson's disease patients discharged from the Middleton Veterans Affairs Hospital Neurology Service to study the incidence of ischemic stroke, myocardial ischemia, tobacco use, and other stroke risk factors. Controls were age and sex matched and were randomly taken from 238 non-Parkinson's disease discharges in which stroke or myocardial infarction was not the reason for hospitalization. RESULTS: The cumulative incidences of ischemic stroke, hypertension, and diabetes mellitus were not significantly different between groups. Myocardial infarction, coronary artery disease, tobacco use, atrial fibrillation, cancer, and ethanol abuse were significantly more prevalent in the controls, whereas dementia and congestive heart failure were the only variables studied that were more prevalent in the Parkinson's disease patients. CONCLUSIONS: Our study failed to demonstrate that Parkinson's disease patients from a Veteran population were protected from ischemic stroke.

This article has been cited by other articles:

				G. Scigliano, M. Musicco, P. Soliveri, I. Piccolo, G. Ronchetti, and F. Girotti Reduced Risk Factors for Vascular Disorders in Parkinson Disease Patients: A Case-Control Study Stroke, May 1, 2006; 37(5): 1184 - 1188. [Abstract] [Full Text] [PDF]

				H Sienkiewicz-Jarosz, A Scinska, W Kuran, D Ryglewicz, A Rogowski, E Wrobel, A Korkosz, A Kukwa, W Kostowski, and P Bienkowski Taste responses in patients with Parkinson's disease J. Neurol. Neurosurg. Psychiatry, January 1, 2005; 76(1): 40 - 46. [Abstract] [Full Text] [PDF]

				R. B. Postuma and A. E. Lang Homocysteine and levodopa: Should Parkinson disease patients receive preventative therapy? Neurology, September 14, 2004; 63(5): 886 - 891. [Abstract] [Full Text] [PDF]

				K. J. Ottenbacher, G. V. Ostir, M. K. Peek, and K. S. Markides Diabetes Mellitus as a Risk Factor for Stroke Incidence and Mortality in Mexican American Older Adults J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2004; 59(6): M640 - M645. [Abstract] [Full Text] [PDF]

				F. Blandini, R. Fancellu, E. Martignoni, A. Mangiagalli, C. Pacchetti, A. Samuele, and G. Nappi Plasma Homocysteine and L-DOPA Metabolism in Patients with Parkinson Disease Clin. Chem., June 1, 2001; 47(6): 1102 - 1104. [Full Text] [PDF]